Although the serum level of total TGF-β1 was upregulated in the CAD patients than in the control samples, Wang and Zhang have shown that the AUC of serum levels of total TGF-β1 in the diagnosis of CAD was only 0.5109 [49]. This evidence concerns the gene TGFB1 and coronary artery disorder.